PURPOSE: Inflammatory cytokines have been implicated in the progression of head and neck squamous cell carcinoma (HNSCC). Herein we investigate the mechanisms by which interleukin-1beta (IL-1beta) might contribute to Epithelial-Mesenchymal Transition (EMT) in HNSCC. EXPERIMENTAL DESIGN: We evaluated the effect of IL-1beta on the molecular events of EMT in surgical specimens and HNSCC cell lines. We examined the correlation with tumor histologic features, and a SCID xenograft model was used to assess the effects of Snail overexpression. RESULTS: Cyclooxygenase-2 (COX-2)-dependent pathways contribute to the modulation of E-cadherin expression in HNSCC. An inverse relationship between COX-2 and E-cadherin was shown in situ by double immunohistochemical staining of human HNSCC tissue sections. Treatment of HNSCC cells with IL-1beta caused the downregulation of E-cadherin expression and upregulation of COX-2 expression. This effect was blocked in the presence of COX-2 small hairpin RNA. IL-1beta-treated HNSCC cell lines showed a significant decrease in E-cadherin mRNA and an increase in the mRNA expression of the transcriptional repressor Snail. IL-1beta exposure led to enhanced Snail binding at the chromatin level. Small hairpin RNA-mediated knockdown of Snail interrupted the capacity of IL-1beta to downregulate E-cadherin. In a SCID xenograft model, HNSCC Snail-overexpressing cells showed significantly increased primary and metastatic tumor burdens. CONCLUSIONS: IL-1beta modulates Snail and thereby regulates COX-2-dependent E-cadherin expression in HNSCC. This is the first report indicating the role of Snail in the inflammation-induced promotion of EMT in HNSCC. This newly defined pathway for transcriptional regulation of E-cadherin in HNSCC has important implications for targeted chemoprevention and therapy.
PURPOSE: Inflammatory cytokines have been implicated in the progression of head and neck squamous cell carcinoma (HNSCC). Herein we investigate the mechanisms by which interleukin-1beta (IL-1beta) might contribute to Epithelial-Mesenchymal Transition (EMT) in HNSCC. EXPERIMENTAL DESIGN: We evaluated the effect of IL-1beta on the molecular events of EMT in surgical specimens and HNSCC cell lines. We examined the correlation with tumor histologic features, and a SCID xenograft model was used to assess the effects of Snail overexpression. RESULTS:Cyclooxygenase-2 (COX-2)-dependent pathways contribute to the modulation of E-cadherin expression in HNSCC. An inverse relationship between COX-2 and E-cadherin was shown in situ by double immunohistochemical staining of human HNSCC tissue sections. Treatment of HNSCC cells with IL-1beta caused the downregulation of E-cadherin expression and upregulation of COX-2 expression. This effect was blocked in the presence of COX-2 small hairpin RNA. IL-1beta-treated HNSCC cell lines showed a significant decrease in E-cadherin mRNA and an increase in the mRNA expression of the transcriptional repressor Snail. IL-1beta exposure led to enhanced Snail binding at the chromatin level. Small hairpin RNA-mediated knockdown of Snail interrupted the capacity of IL-1beta to downregulate E-cadherin. In a SCID xenograft model, HNSCC Snail-overexpressing cells showed significantly increased primary and metastatic tumor burdens. CONCLUSIONS:IL-1beta modulates Snail and thereby regulates COX-2-dependent E-cadherin expression in HNSCC. This is the first report indicating the role of Snail in the inflammation-induced promotion of EMT in HNSCC. This newly defined pathway for transcriptional regulation of E-cadherin in HNSCC has important implications for targeted chemoprevention and therapy.
Authors: M Dohadwala; J Luo; L Zhu; Y Lin; G J Dougherty; S Sharma; M Huang; M Pold; R K Batra; S M Dubinett Journal: J Biol Chem Date: 2001-04-24 Impact factor: 5.157
Authors: J S Wolf; Z Chen; G Dong; J B Sunwoo; C C Bancroft; D E Capo; N T Yeh; N Mukaida; C Van Waes Journal: Clin Cancer Res Date: 2001-06 Impact factor: 12.531
Authors: Robert P Takes; Robert J Baatenburg De Jong; Martijn J R C Alles; Cees A Meeuwis; Henri A M Marres; Paul P M Knegt; Guy Brutel De La Riviere; Peter C M De Wilde; Wolter J Mooi; Jo Hermans; J Han J M Van Krieken Journal: Arch Otolaryngol Head Neck Surg Date: 2002-05
Authors: Samir E Witta; Robert M Gemmill; Fred R Hirsch; Christopher D Coldren; Karla Hedman; Larisa Ravdel; Barbara Helfrich; Rafal Dziadziuszko; Daniel C Chan; Michio Sugita; Zeng Chan; Anna Baron; Wilbur Franklin; Harry A Drabkin; Luc Girard; Adi F Gazdar; John D Minna; Paul A Bunn Journal: Cancer Res Date: 2006-01-15 Impact factor: 12.701
Authors: Brigitte N Gomperts; Avrum Spira; Pierre P Massion; Tonya C Walser; Ignacio I Wistuba; John D Minna; Steven M Dubinett Journal: Semin Respir Crit Care Med Date: 2011-04-15 Impact factor: 3.119
Authors: Christopher H Switzer; Sharon A Glynn; Robert Y-S Cheng; Lisa A Ridnour; Jeffrey E Green; Stefan Ambs; David A Wink Journal: Mol Cancer Res Date: 2012-08-09 Impact factor: 5.852
Authors: Abie H Mendelsohn; Chi K Lai; I Peter Shintaku; Michael C Fishbein; Katherine Brugman; David A Elashoff; Elliot Abemayor; Steven M Dubinett; Maie A St John Journal: Am J Otolaryngol Date: 2011-03-24 Impact factor: 1.808
Authors: Silvana Papagerakis; Giuseppe Pannone; Li Zheng; Imad About; Nawar Taqi; Nghia P T Nguyen; Margarite Matossian; Blake McAlpin; Angela Santoro; Jonathan McHugh; Mark E Prince; Petros Papagerakis Journal: Exp Cell Res Date: 2014-05-05 Impact factor: 3.905
Authors: Miranda Dennis; Guanyu Wang; Jie Luo; Yuan Lin; Mariam Dohadwala; Elliot Abemayor; David A Elashoff; Sherven Sharma; Steven M Dubinett; Maie A St John Journal: Otolaryngol Head Neck Surg Date: 2012-05-07 Impact factor: 3.497